Donal McLornan/guysandstthomas.nhs.uk
Mar 31, 2025, 13:24
Donal McLornan: Practical online tool to aid the transplant decision and discussion
Donal McLornan, Consultant in Haematology and Stem Cell Transplantation at UCLH, shared a post by ASH on X, adding:
“Prediction of outcomes post allo-HCT in Myelofibrosis via ML.
Practical online tool to aid the transplant decision and discussion.”
Quoting ASH‘s post:
“This tool outperformed standard models in accuracy, identifying a subset of high-risk patients with a 40% chance of dying within a year after transplant – 25% of patients with myelofibrosis. This data helps patients weigh disease-related risk factors when considering a transplant.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 1, 2025, 12:48
Apr 1, 2025, 12:16
Apr 1, 2025, 12:13
Apr 1, 2025, 12:07
Apr 1, 2025, 11:53